1. Home
  2. Analysis
  3. Daliresp
  4. Urticaria

Daliresp and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Daliresp (roflumilast), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Mucinex, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Urticaria when taking Daliresp. It is created by eHealthMe based on reports of 4,674 people who have side effects when taking Daliresp from the FDA, and is updated regularly.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,618 drugs and 2,953 conditions by eHealthMe. Check the latest studies of Urticaria.

On Jul, 20, 2026

4,674 people reported to have side effects when taking Daliresp.
Among them, 32 people (0.68%) have Urticaria.

Could Daliresp cause Urticaria?

Among these 32 people:

How long have people been on Daliresp when they have Urticaria? *

  • < 1 month: 60 %
  • 1 - 6 months: 20 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 20 %
  • 10+ years: 0.0 %

What is the gender of people who have Urticaria when taking Daliresp? *

  • female: 84.38 %
  • male: 15.62 %

What is the age of people who have Urticaria when taking Daliresp? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 28.57 %
  • 60+: 71.43 %

What are other drugs people take besides Daliresp? *

  1. Mucinex: 9 people, 28.12%
  2. Epinephrine: 8 people, 25.00%
  3. Spiriva: 8 people, 25.00%
  4. Trelegy Ellipta: 7 people, 21.88%
  5. Lexapro: 7 people, 21.88%
  6. Fluticasone Propionate: 7 people, 21.88%
  7. Aspirin: 6 people, 18.75%
  8. Albuterol Sulfate: 6 people, 18.75%
  9. Furosemide: 6 people, 18.75%
  10. Azithromycin: 6 people, 18.75%

What are other side effects people have besides Urticaria? *

  1. Rashes (redness): 14 people, 43.75%
  2. Pneumonia: 9 people, 28.12%
  3. Dyspnea (difficult or laboured breathing): 8 people, 25.00%
  4. Sinusitis (inflammation of sinus): 7 people, 21.88%
  5. Itching: 7 people, 21.88%
  6. Back Pain: 5 people, 15.62%
  7. Chest Pain: 4 people, 12.50%
  8. Fatigue (feeling of tiredness): 4 people, 12.50%
  9. Rash Erythematous (redness of the skin): 4 people, 12.50%
  10. Stress And Anxiety: 4 people, 12.50%

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 8 people, 25.00%
  2. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 3 people, 9.38%
  3. Swelling: 1 person, 3.12%
  4. Bipolar Disorder (mood disorder): 1 person, 3.12%
  5. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 3.12%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 3.12%
  7. Chronic Respiratory Failure: 1 person, 3.12%
  8. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 3.12%
  9. Drowsiness: 1 person, 3.12%
  10. Hyperkalemia (damage to or disease of the kidney): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Daliresp and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daliresp:

Urticaria treatments and more:

How severe was Urticaria and when was it recovered:

Expand to all the drugs that have ingredients of roflumilast:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Browse all the conditions that are associated with Urticaria:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on roflumilast (the active ingredients of Daliresp) and Daliresp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.